{"protocolSection":{"identificationModule":{"nctId":"NCT05517109","orgStudyIdInfo":{"id":"IVT-160"},"organization":{"fullName":"Northern State Medical University","class":"OTHER"},"briefTitle":"Hemodynamic in Postreperfusion Period and Functional Recovery in Acute Ischemic Stroke Patients","officialTitle":"The Influence of Different Hemodynamic Parameters in First 24 Hours After Intravenous Thrombolysis on Acute Ischemic Stroke Outcomes: A Randomised Clinical Trial"},"statusModule":{"statusVerifiedDate":"2022-08","overallStatus":"RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2022-03-12","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2024-09-30","type":"ESTIMATED"},"completionDateStruct":{"date":"2024-12-29","type":"ESTIMATED"},"studyFirstSubmitDate":"2022-08-06","studyFirstSubmitQcDate":"2022-08-25","studyFirstPostDateStruct":{"date":"2022-08-26","type":"ACTUAL"},"lastUpdateSubmitDate":"2022-08-25","lastUpdatePostDateStruct":{"date":"2022-08-26","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Northern State Medical University","class":"OTHER"}},"oversightModule":{"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false,"isUsExport":false},"descriptionModule":{"briefSummary":"The investigators are suggtesting that lower goals of systolic blood pressure after intravenous thrombolysis may reduce the risk of hemorrhagic complications and improve functional outcomes after acute ischemic stroke."},"conditionsModule":{"conditions":["Acute Ischemic Stroke","Intracranial Hemorrhage"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"PREVENTION","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":100,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Control group. Standart care","type":"NO_INTERVENTION","description":"Standart hemodynamic goals: systolic blood pressure 160-185 mmHg in first 24 hours after intravenous thrombolysis"},{"label":"Systolic blood pressure ≤ 160 mmHg","type":"EXPERIMENTAL","description":"Lower hemodynamic goals: systolic blood pressure ≤ 160 mmHg in first 24 hours after intravenous thrombolysis","interventionNames":["Other: Hemodynamic goal including lower goal of systolic blood pressure"]}],"interventions":[{"type":"OTHER","name":"Hemodynamic goal including lower goal of systolic blood pressure","description":"Different hemodynamic goals in different study arms","armGroupLabels":["Systolic blood pressure ≤ 160 mmHg"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Modified Rankin Scale score","description":"Fucntional outcome (Modified Rankin Scale) will be assesed by telephone interview. Score from 0 to 6. Higher scores mean a worse outcome.","timeFrame":"90 day after intravenous thrombolysis"},{"measure":"Mortality rate","timeFrame":"At 90 day after intravenous thrombolysis"},{"measure":"Rate of symptomatic intracranial hemorrhage","description":"Symptomatic intracranial hemorrhage (sICH) according to SITS-MOST study description of sICH","timeFrame":"24 hours after intravenous thrombolysis"},{"measure":"Rate of symptomatic intracranial hemorrhage","description":"Symptomatic intracranial hemorrhage (sICH) according to SITS-MOST study description of sICH","timeFrame":"7 days after intravenous thrombolysis"}],"secondaryOutcomes":[{"measure":"Change in National Institutes of Health Stroke Scale (NIHSS)","description":"Score form 0 to 42. Higher score indicates worse outcome","timeFrame":"at 28 day after intravenous thrombolysis"},{"measure":"Rate of all Intracranial hemorrhage","description":"Intracranial hemorrhage will be classified according to Heidelberg bleeding classification","timeFrame":"24 hours after intravenous thrombolysis"},{"measure":"Rate of all Intracranial hemorrhage","description":"Intracranial hemorrhage will be classified according to Heidelberg bleeding classification","timeFrame":"7 days after intravenous thrombolysis"},{"measure":"Lengths of stay in ICU","timeFrame":"at 90 day after intravenous thrombolysis"},{"measure":"Lengths of stay in hospital","timeFrame":"at 90 day after intravenous thrombolysis"},{"measure":"Rate of acute kidney injury","description":"Acute kidney injury will be assesed according to RIFLE Classification","timeFrame":"28 day after intravenous thrombolysis or at discharge"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion сriteria:\n\n* ischemic stroke diagnosis\n* performed intravenous thrombolysis (including \"wake up stroke\")\n* systolic blood pressure \\>140 mmHg\n* informed consent or council of physician agreement\n\nExclusion criteria:\n\n* absence of informed consent or council of physician agreement\n* pregnancy\n* patients participainting in other clinical trial in the last 90 days\n* any absolute contraindications to intravenous thrombolysis\n\nСompletion criteria:\n\n* failure to achieve hemodynamic goal for 20 minutes before the start of intravenous thrombolysis\n* failure to achieve hemodynamic goal for 60 minutes in first 24 hours after intravenous thrombolysis\n* relative arterial hypotension (SBP \\<100 mmHg for 60 minutes in first 24 hours after intravenous thrombolysis)\n* unfavorable effect development (e.g. seizures, angioedema)\n* informed consent is retracted","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"centralContacts":[{"name":"Alexey Avidzba","role":"CONTACT","phone":"9115905137","phoneExt":"+7","email":"avidzba_a@rambler.ru"}],"overallOfficials":[{"name":"Mikhail Kirov, PhD","affiliation":"Northen state medical university","role":"STUDY_DIRECTOR"},{"name":"Alexey Avidzba","affiliation":"Northen state medical university","role":"STUDY_CHAIR"}],"locations":[{"facility":"City Hospital # 1 n.a. E.E. Volosevich","status":"RECRUITING","city":"Arkhangelsk","zip":"163000","country":"Russian Federation","contacts":[{"name":"Mikhail Kirov, PhD","role":"CONTACT","email":"mikhail_kirov@hotmail.com"}],"geoPoint":{"lat":64.5401,"lon":40.5433}}]},"ipdSharingStatementModule":{"ipdSharing":"YES","description":"All IPD that underlie results in a publication","infoTypes":["STUDY_PROTOCOL"]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000083242","term":"Ischemic Stroke"},{"id":"D000002544","term":"Cerebral Infarction"},{"id":"D000020300","term":"Intracranial Hemorrhages"},{"id":"D000007511","term":"Ischemia"},{"id":"D000006470","term":"Hemorrhage"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000010335","term":"Pathologic Processes"},{"id":"D000020520","term":"Brain Infarction"},{"id":"D000002545","term":"Brain Ischemia"},{"id":"D000007238","term":"Infarction"},{"id":"D000009336","term":"Necrosis"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M9246","name":"Hemorrhage","asFound":"Hemorrhage","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","asFound":"Ischemic","relevance":"HIGH"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M21803","name":"Intracranial Hemorrhages","asFound":"Intracranial Hemorrhage","relevance":"HIGH"},{"id":"M9972","name":"Infarction","relevance":"LOW"},{"id":"M5483","name":"Cerebral Infarction","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M21995","name":"Brain Infarction","relevance":"LOW"},{"id":"M5484","name":"Brain Ischemia","relevance":"LOW"},{"id":"M11974","name":"Necrosis","relevance":"LOW"},{"id":"T170","name":"Acute Graft Versus Host Disease","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"Rare","name":"Rare Diseases"}]}},"hasResults":false}